Agios Pharmaceuticals (AGIO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Agios Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$36.50M

Latest Revenue (Q)

$12.46M

Main Segment (Y)

Product

Agios Pharmaceuticals Revenue by Period

Agios Pharmaceuticals Revenue by Year

Date	Revenue	Change
2024-12-31	$36.50M	36.07%
2023-12-31	$26.82M	88.36%
2022-12-31	$14.24M	100.00%
2021-12-31	-	-100.00%
2020-12-31	$203.20M	72.33%
2019-12-31	$117.91M	24.92%
2018-12-31	$94.39M	119.45%
2017-12-31	$43.01M	-38.46%
2016-12-31	$69.89M	18.22%
2015-12-31	$59.12M	-9.55%
2014-12-31	$65.36M	155.82%
2013-12-31	$25.55M	1.76%
2012-12-31	$25.11M	14.97%
2011-12-31	$21.84M	-

Agios Pharmaceuticals generated $36.50M in revenue during NA 2024, up 36.07% compared to the previous quarter, and up 30.95% compared to the same period a year ago.

Agios Pharmaceuticals Revenue by Quarter

Date	Revenue	Change
2025-06-30	$12.46M	42.73%
2025-03-31	$8.73M	-18.68%
2024-12-31	$10.73M	19.70%
2024-09-30	$8.96M	4.05%
2024-06-30	$8.62M	5.20%
2024-03-31	$8.19M	15.29%
2023-12-31	$7.10M	-4.00%
2023-09-30	$7.40M	10.24%
2023-06-30	$6.71M	19.66%
2023-03-31	$5.61M	30.14%
2022-12-31	$4.31M	22.58%
2022-09-30	$3.52M	-37.01%
2022-06-30	$5.58M	570.91%
2022-03-31	$832.00K	100.00%
2021-12-31	-	100.00%
2021-09-30	-	-100.00%
2021-06-30	$37.35M	-9.81%
2021-03-31	$41.41M	-5.98%
2020-12-31	$44.05M	26.91%
2020-09-30	$34.71M	-7.07%
2020-06-30	$37.35M	-57.12%
2020-03-31	$87.10M	145.76%
2019-12-31	$35.44M	36.18%
2019-09-30	$26.02M	-0.75%
2019-06-30	$26.22M	-13.25%
2019-03-31	$30.23M	0.71%
2018-12-31	$30.01M	97.48%
2018-09-30	$15.20M	-62.39%
2018-06-30	$40.41M	361.24%
2018-03-31	$8.76M	-10.58%
2017-12-31	$9.80M	-13.73%
2017-09-30	$11.36M	0.11%
2017-06-30	$11.35M	7.97%
2017-03-31	$10.51M	-53.60%
2016-12-31	$22.65M	152.06%
2016-09-30	$8.98M	28.76%
2016-06-30	$6.98M	-77.69%
2016-03-31	$31.28M	403.07%
2015-12-31	$6.22M	13.47%
2015-09-30	$5.48M	-58.54%
2015-06-30	$13.22M	-61.35%
2015-03-31	$34.20M	133.68%
2014-12-31	$14.64M	-56.83%
2014-09-30	$33.90M	303.04%
2014-06-30	$8.41M	-
2014-03-31	$8.41M	24.72%
2013-12-31	$6.74M	7.59%
2013-09-30	$6.27M	-
2013-06-30	$6.27M	-
2013-03-31	$6.27M	-0.22%
2012-12-31	$6.28M	0.22%
2012-09-30	$6.27M	-0.32%
2012-06-30	$6.29M	0.32%
2012-03-31	$6.27M	-

Agios Pharmaceuticals generated $12.46M in revenue during Q2 2025, up 42.73% compared to the previous quarter, and up 152.09% compared to the same period a year ago.

Agios Pharmaceuticals Revenue Breakdown

Agios Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 20	Dec 19
Product	$36.50M	$26.82M	$11.74M	$121.09M	$59.85M
Royalty	-	-	$2.50M	$10.26M	$10.54M
Development Activities	-	-	-	-	-
Research Services	-	-	-	$64.35M	$35.95M
Collaboration Revenue, Related Party	-	-	-	$68.27M	$39.26M
Commercialization Activity	-	-	-	$3.93M	$3.30M
Committee Participation	-	-	-	-	-
Collaboration Revenue, Other	-	-	-	-	$8.26M

Agios Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Quarterly Revenue by Product

Product/Service	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Product	$12.46M	$8.73M	$10.73M	$8.96M	$8.62M	$8.19M	$7.10M	$7.40M	$6.71M	$5.61M	$4.31M	$3.52M	$3.08M	$832.00K	$39.12M	$31.72M	$27.58M	$22.67M	$19.56M	-
Royalty	-	-	-	-	-	-	-	-	-	$2.91M	$683.00K	$3.34M	$3.33M	$2.97M	-	-	-	-	-	-
Collaboration Revenue, Related Party	-	-	-	-	-	-	-	-	-	-	-	-	$2.50M	$1.24M	$1.21M	$5.74M	$60.10M	$6.84M	$5.52M	-
Research Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$214.00K	$6.04M	-	-	-	-
Commercialization Activity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.02M	$804.00K	$821.00K	-	-	-
Collaboration Revenue, Other	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$6.06M	-
DevelopmentActivitiesMember	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
ResearchServicesMember	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$4.70M

Agios Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (100.00%).

Agios Pharmaceuticals Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CPRX	Catalyst Pharmaceuticals	$491.73M	$141.42M
GLPG	Galapagos	$239.70M	$62.43M
TVTX	Travere Therapeutics	$233.18M	$114.45M
ADPT	Adaptive Bio	$178.96M	$58.88M
RXRX	Recursion Pharmaceuticals	$58.84M	$19.22M
AGIO	Agios Pharmaceuticals	$36.50M	$12.46M
IBRX	ImmunityBio	$14.74M	$26.43M
IDYA	IDEAYA Biosciences	$7.00M	-
ETNB	89bio	-	-
DYN	Dyne Therapeutics	-	-
DNLI	Denali Therapeutics	-	-

AGIO Revenue FAQ

What is Agios Pharmaceuticals’s yearly revenue?

Agios Pharmaceuticals's yearly revenue for 2024 was $36.5M, representing an increase of 36.07% compared to 2023. The company's yearly revenue for 2023 was $26.82M, representing an increase of 88.36% compared to 2022. AGIO's yearly revenue for 2022 was $14.24M, representing an increase of 100.00% compared to 2021.

What is Agios Pharmaceuticals’s quarterly revenue?

Agios Pharmaceuticals's quarterly revenue for Q2 2025 was $12.46M, a 42.73% increase from the previous quarter (Q1 2025), and a 44.57% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $8.73M, a -18.68% decrease from the previous quarter (Q4 2024), and a 6.56% increase year-over-year (Q1 2024). AGIO's quarterly revenue for Q4 2024 was $10.73M, a 19.70% increase from the previous quarter (Q3 2024), and a 51.06% increase year-over-year (Q4 2023).

What is Agios Pharmaceuticals’s revenue growth rate?

Agios Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 156.31%, and for the last 5 years (2020-2024) was -82.04%.

What are Agios Pharmaceuticals’s revenue streams?

Agios Pharmaceuticals's revenue streams in c 24 are Product

What is Agios Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Agios Pharmaceuticals was Product. This segment made a revenue of $36.5M, representing 100.00% of the company's total revenue.